Publications by authors named "Cecile Droz"

Claim this Profile
C
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, Yves Cottin, Patrick Mismetti, Cécile Droz

Am J Cardiovasc Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Ibuprofen Worsen COVID-19?
Nicholas Moore, Bruce Carleton, Patrick Blin, Pauline Bosco-Levy, Cecile Droz

Drug Saf· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Stéphane Ducassou, Anne Gourdonneau, Helder Fernandes, Guy Leverger, Marlène Pasquet, Cécile Droz

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, Yves Cottin, Patrick Mismetti, Cécile Droz

Am J Cardiovasc Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoepidemiology.
Nicholas Moore, Patrick Blin, Cécile Droz

Handb Exp Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database.
Patrick Blin, Caroline Dureau-Pournin, Jérémy Jové, Regis Lassalle, Cécile Droz

MethodsX· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance - The next chapter.
Nicholas Moore, Driss Berdaï, Patrick Blin, Cécile Droz

Therapie· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.
Luisa Ibáñez, Mònica Sabaté, Xavier Vidal, Elena Ballarin, Marietta Rottenkolber, Cécile Droz

Br J Clin Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation.
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, Jacques Bénichou, Patrick Mismetti, Cécile Droz

Clin Pharmacol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoepidemiology of non-steroidal anti-inflammatory drugs.
Nicholas Moore, Mai Duong, Sinem Ezgi Gulmez, Patrick Blin, Cecile Droz

Therapie· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study.
Amandine Gouverneur, Juliette Coutureau, Jérémy Jové, Magali Rouyer, Angela Grelaud, Cécile Droz

Clin Colorectal Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, Jacques Bénichou, Patrick Mismetti, Cécile Droz

Br J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.
Patrick Blin, Caroline Dureau-Pournin, Jacques Benichou, Laurent Bonello, Jean Dallongeville, Cécile Droz

Atherosclerosis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample.
Mai Duong, Abdelilah Abouelfath, Regis Lassalle, Cécile Droz, Patrick Blin

Drug Saf· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Julien Bezin, Mai Duong, Régis Lassalle, Cécile Droz, Antoine Pariente

Pharmacoepidemiol Drug Saf· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usage patterns of paracetamol in France.
Mai Duong, Sinem Ezgi Gulmez, Francesco Salvo, Abdelilah Abouelfath, Régis Lassalle, Cécile Droz

Br J Clin Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.
Mai Duong, Francesco Salvo, Antoine Pariente, Abdelilah Abouelfath, Regis Lassalle, Cecile Droz

Br J Clin Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of antibiotics for acute sinusitis in real-life medical practice.
Patrick Blin, Sylvie Blazejewski, Séverine Lignot, Régis Lassalle, Marie-Agnès Bernard, Cécile Droz

Br J Clin Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.
Michel Rossignol, Abdelilah Abouelfath, Regis Lassalle, Yvon Merlière, Cécile Droz

Br J Clin Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.
Gilles Raguin, Geneviève Chêne, Laurence Morand-Joubert, Anne-Marie Taburet, Cécile Droz

Antivir Ther· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.
Anne-Marie Taburet, Gilles Raguin, Clotilde Le Tiec, Cécile Droz, Aurélie Barrail

Clin Pharmacol Ther· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
Bernard Masquelier, Cecile Droz, Martin Dary, Christian Perronne, Virginie Ferré

Antimicrob Agents Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.
Bernard Masquelier, Gilles Peytavin, Catherine Leport, Cecile Droz, Ségolène Duran

J Infect Dis· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis